OPKO Health, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
OPKO Health, Inc. (OPK) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2016-02-29
- 2015-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2015-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$1.40M.
- 2015-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$7.80M.
- 2015-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$7.33M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2015-09-30 | -$1.40M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$7.80M 10-Q · filed 2015-08-05 |
| 2015-03-31 | -$7.33M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$6.40M 10-K · filed 2016-02-29 |
| 2014-09-30 | -$5.91M 10-Q · filed 2014-11-07 |
| 2014-06-30 | -$4.57M 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$3.97M 10-Q · filed 2014-05-09 |
| 2013-12-31 | -$3.43M 10-K · filed 2015-02-27 |
| 2013-09-30 | -$2.80M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$2.00M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$1.04M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$492.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |